Aflac Ventures

Aflac Ventures is the corporate venture arm of Aflac, the Columbus, Georgia-headquartered supplemental insurance company. The fund’s strategic mandate is shaped by its parent’s interest in benefits, employer-paid insurance, and adjacent health services, which positions its healthcare deployments squarely within digital health and health IT software rather than clinical therapeutics or regulated medical devices. Investments target companies whose products extend, integrate with, or complement Aflac’s core insurance and benefits distribution.

The fund participates at Series A, Series B and Series C stages, with check sizes typically in the $1M to $5M range. Geographic activity is concentrated in the United States, consistent with Aflac’s primary commercial footprint and the regulatory environment in which its insurance products operate. Aflac Ventures generally invests as a strategic participant in syndicated rounds led by financial venture firms, contributing capital alongside structural value tied to Aflac’s customer relationships, distribution channels, and benefits ecosystem rather than competing for lead-investor status.

For founders, Aflac Ventures is a strategic capital partner most relevant to digital health and health IT companies whose offerings align with employer benefits, claims experience, or member engagement. Engagement typically involves a defined exploration of commercial fit with Aflac’s business units, alongside standard equity-investor diligence. Founders should plan for governance terms appropriate to a strategic minority investor, with information rights but limited operational interference. The fund is best suited to growth-stage companies seeking a corporate validation signal and meaningful partnership exploration with a major US benefits carrier, rather than to teams seeking a lead financial investor or hands-on portfolio operations support.